Deep Value: cash covers more than 100% of the stock price

This company holds roughly $40M in cash and investments — more than its entire stock-market value, based on its latest quarterly filing. You're paying very little for the actual business. Sometimes that's a genuine bargain or a takeover target, sometimes it's cheap for a reason. Not a buy signal on its own — always ask why it's this cheap.

Retractable Technologies

RVP

Medical - Instruments & Supplies · Healthcare

Price

$0.73

+0.00 (+0.00%)

Market Cap

$21.9M

Exchange

New York Stock Exchange Arca

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Weak

Growth

Mixed

Cash Flow

Weak

Stability

Good

Valuation

Data not available

Track this stock — start free trial

Share count falling — buybacks

−12.6% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 34.2M (2021) → 29.9M (2025)

Winston Score History

The full picture

Retractable Technologies makes safety syringes and other medical devices designed to reduce accidental needle-stick injuries for healthcare workers. Its main products include the VanishPoint syringe, which automatically retracts the needle after use, along with safety blood collection tubes and face masks. The company sells primarily to hospitals, clinics, and healthcare distributors in the United States and internationally.

The company earns revenue by selling its disposable medical products directly and through distributors, with the U.S. market being its largest. It is a relatively small manufacturer competing against much larger medical supply companies like Becton Dickinson, which creates significant pricing pressure. The extremely thin gross margin of around 1% and deep operating losses signal that the company is currently struggling to cover its costs, and its main challenge going forward is scaling production and winning enough contracts to reach profitability against well-entrenched, lower-cost competitors.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-31.1% YoY

YoY Growth Rate

Revenue declining

EPS Growth

>+1,000% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$675,567/ year

→ Flat (+0% vs prior year)

1.8% of revenue

Below sector average (18%)

Steady R&D investment year-over-year

Insider Activity

59.2%ownership

Insiders own a meaningful stake in the company

Cash Runway

~6 years

$40M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

$40M cash & investments at current burn rate

Revenue declining

Retractable Technologies's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

2.7%

Thin — 2.7% gross margin

Profit after running costs

Operating Margin

-71.5%

Losing money on operations — -71.5%

Return on the money invested

ROCE

-30.8%

Weak — -30.8% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-11.2%

Shrinking sales (-11.2% YoY)

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

6/8 quarters

Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

-15.1%

Burning cash (-15.1%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.01

Conservative — low debt load (0.01)

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial